Pulmonary inflammation after lung transplantation.
作者信息
Laubach Victor E, Kron Irving L
机构信息
Department of Surgery, University of Virginia Health System, Charlottesville, VA 22908, USA.
出版信息
Surgery. 2009 Jul;146(1):1-4. doi: 10.1016/j.surg.2009.02.011. Epub 2009 May 8.
Abstract
摘要
相似文献
1
Pulmonary inflammation after lung transplantation.
Surgery. 2009 Jul;146(1):1-4. doi: 10.1016/j.surg.2009.02.011. Epub 2009 May 8.
2
Pretreatment strategy with adenosine A2A receptor agonist attenuates reperfusion injury in a preclinical porcine lung transplantation model.
J Thorac Cardiovasc Surg. 2011 Oct;142(4):887-94. doi: 10.1016/j.jtcvs.2011.06.015. Epub 2011 Jul 16.
3
Ex vivo lung perfusion with adenosine A2A receptor agonist allows prolonged cold preservation of lungs donated after cardiac death.
J Thorac Cardiovasc Surg. 2016 Feb;151(2):538-45. doi: 10.1016/j.jtcvs.2015.07.075. Epub 2015 Jul 30.
4
Adenosine A2A receptor activation reduces inflammation and preserves pulmonary function in an in vivo model of lung transplantation.
J Thorac Cardiovasc Surg. 2005 May;129(5):1137-43. doi: 10.1016/j.jtcvs.2004.11.042.
5
Pulmonary macrophages are involved in reperfusion injury after lung transplantation.
Ann Thorac Surg. 2001 Apr;71(4):1134-8; discussion 1138-9. doi: 10.1016/s0003-4975(01)02407-9.
6
[Ischemia-reperfusion injury after lung transplantation].
Presse Med. 2014 Sep;43(9):921-30. doi: 10.1016/j.lpm.2014.01.018. Epub 2014 Jun 13.
7
Lung Ischemia-Reperfusion is a Sterile Inflammatory Process Influenced by Commensal Microbiota in Mice.
Shock. 2015 Sep;44(3):272-9. doi: 10.1097/SHK.0000000000000415.
8
Additive protection against lung ischemia-reperfusion injury by adenosine A2A receptor activation before procurement and during reperfusion.
J Thorac Cardiovasc Surg. 2008 Jan;135(1):156-65. doi: 10.1016/j.jtcvs.2007.08.041. Epub 2007 Nov 26.
9
Adenosine A2A receptor-selective stimulation reduces signaling pathways involved in the development of intestine ischemia and reperfusion injury.
Shock. 2010 May;33(5):541-51. doi: 10.1097/SHK.0b013e3181c997dd.
10
Alveolar epithelial fluid transport capacity in reperfusion lung injury after lung transplantation.
Am J Respir Crit Care Med. 1999 Mar;159(3):980-8. doi: 10.1164/ajrccm.159.3.9802105.
引用本文的文献
1
Targeting FoxO proteins induces lytic reactivation of KSHV for treating herpesviral primary effusion lymphoma.
PLoS Pathog. 2023 Aug 18;19(8):e1011581. doi: 10.1371/journal.ppat.1011581. eCollection 2023 Aug.
2
Plasma protein biomarkers for primary graft dysfunction after lung transplantation: a single-center cohort analysis.
Sci Rep. 2022 Sep 27;12(1):16137. doi: 10.1038/s41598-022-20085-y.
3
Incidence of primary graft dysfunction is higher according to the new ISHLT 2016 guidelines and correlates with clinical and molecular risk factors.
J Thorac Dis. 2021 Jun;13(6):3426-3442. doi: 10.21037/jtd-20-3564.
4
Investigation of the preventive effect of proanthocyanidin in ischemia-reperfusion injury in lung transplantation: An experimental study.
Turk Gogus Kalp Damar Cerrahisi Derg. 2018 Sep 16;26(4):606-613. doi: 10.5606/tgkdc.dergisi.2018.16078. eCollection 2018 Oct.
5
Adiponectin protects against lung ischemia-reperfusion injury in rats with type 2 diabetes mellitus.
Mol Med Rep. 2018 May;17(5):7191-7201. doi: 10.3892/mmr.2018.8748. Epub 2018 Mar 14.
6
Adenosine A1 receptor activation attenuates lung ischemia-reperfusion injury.
J Thorac Cardiovasc Surg. 2013 Jun;145(6):1654-9. doi: 10.1016/j.jtcvs.2013.01.006. Epub 2013 Feb 8.
7
Adenosine A₂A agonist improves lung function during ex vivo lung perfusion.
Ann Thorac Surg. 2011 Nov;92(5):1840-6. doi: 10.1016/j.athoracsur.2011.06.062. Epub 2011 Oct 31.
8
Reactive oxygen species hydrogen peroxide mediates Kaposi's sarcoma-associated herpesvirus reactivation from latency.
PLoS Pathog. 2011 May;7(5):e1002054. doi: 10.1371/journal.ppat.1002054. Epub 2011 May 19.
9
Mechanisms of Kaposi's Sarcoma-Associated Herpesvirus Latency and Reactivation.
Adv Virol. 2011;2011. doi: 10.1155/2011/193860.
10
Clinical translation of nitrite therapy for cardiovascular diseases.
Nitric Oxide. 2010 Feb 15;22(2):91-7. doi: 10.1016/j.niox.2009.11.001. Epub 2009 Nov 10.
本文引用的文献
1
CD4+ T lymphocytes mediate acute pulmonary ischemia-reperfusion injury.
J Thorac Cardiovasc Surg. 2009 Mar;137(3):695-702; discussion 702. doi: 10.1016/j.jtcvs.2008.10.044.
2
NADPH oxidase in bone marrow-derived cells mediates pulmonary ischemia-reperfusion injury.
Am J Respir Cell Mol Biol. 2009 Mar;40(3):375-81. doi: 10.1165/rcmb.2008-0300OC. Epub 2008 Sep 11.
3
Alveolar macrophage activation is a key initiation signal for acute lung ischemia-reperfusion injury.
Am J Physiol Lung Cell Mol Physiol. 2006 Nov;291(5):L1018-26. doi: 10.1152/ajplung.00086.2006. Epub 2006 Jul 21.
4
Update of early respiratory failure in the lung transplant recipient.
Curr Opin Crit Care. 2006 Feb;12(1):19-24. doi: 10.1097/01.ccx.0000198995.44943.63.
5
Adenosine A2A receptor activation reduces inflammation and preserves pulmonary function in an in vivo model of lung transplantation.
J Thorac Cardiovasc Surg. 2005 May;129(5):1137-43. doi: 10.1016/j.jtcvs.2004.11.042.
6
Tumor necrosis factor-alpha from resident lung cells is a key initiating factor in pulmonary ischemia-reperfusion injury.
J Thorac Cardiovasc Surg. 2004 Feb;127(2):541-7. doi: 10.1016/j.jtcvs.2003.09.008.
7
Ischemia-reperfusion injury after lung transplantation increases risk of late bronchiolitis obliterans syndrome.
Ann Thorac Surg. 2002 Apr;73(4):1041-7; discussion 1047-8. doi: 10.1016/s0003-4975(01)03606-2.
8
Lung transplant reperfusion injury involves pulmonary macrophages and circulating leukocytes in a biphasic response.
J Thorac Cardiovasc Surg. 2001 Jun;121(6):1069-75. doi: 10.1067/mtc.2001.113603.
9
Mediators of ischemia-reperfusion injury of rat lung.
Am J Pathol. 1997 May;150(5):1773-84.
10
Evolving strategies in lung transplantation for emphysema.
Ann Thorac Surg. 1994 Jun;57(6):1513-20; discussion 1520-1. doi: 10.1016/0003-4975(94)90111-2.
Zotero 插件